4.7 Article

Antibacterial and safety tests of a flexible cold atmospheric plasma device for the stimulation of wound healing

期刊

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
卷 105, 期 5, 页码 2057-2070

出版社

SPRINGER
DOI: 10.1007/s00253-021-11166-5

关键词

Dielectric barrier discharge; Skin wound model; Healthy volunteers; Pseudomonas aeruginosa; Methicillin-resistant Staphylococcus aureus (MRSA)

资金

  1. Dutch Burns Foundation [14.200]
  2. ZonMw [40-41200-98-9189]

向作者/读者索取更多资源

Cold atmospheric plasma (CAP) devices can be used as an alternative antimicrobial treatment for chronic wounds, showing good efficacy against Staphylococcus aureus but less effective on dermal samples. CAP treatment did not affect cellular activity or DNA integrity of human dermal samples. Treatment with CAP can lead to a temporarily increased local skin temperature and increased erythema.
Cold atmospheric plasma (CAP) devices generate an ionized gas with highly reactive species and electric fields at ambient air pressure and temperature. A flexible dielectric barrier discharge (DBD) was developed as an alternative antimicrobial treatment for chronic wounds. Treatment of Staphylococcus aureus in collagen-elastin matrices with CAP for 2 min resulted in a 4 log reduction. CAP treatment was less effective on S. aureus on dermal samples. CAP did not affect cellular activity or DNA integrity of human dermal samples when used for up to 2 min. Repeated daily CAP treatments for 2 min lowered cellular activity of dermal samples to 80% after 2 to 4 days, but this was not significant. Repeated treatment of ex vivo human burn wound models with CAP for 2 min did not affect re-epithelialization. Intact skin of 25 healthy volunteers was treated with CAP for 3x 20 to determine safety. Although participants reported moderate pain scores (numerical rating scale 3.3), all volunteers considered the procedure to be acceptable. Severe adverse events did not occur. CAP treatment resulted in a temporarily increased local skin temperature (approximate to 3.4 degrees C) and increased erythema. Lowering the plasma power resulted in a significantly lower erythema increase. Good log reduction (2.9) of bacterial load was reached in 14/15 volunteers artificially contaminated with Pseudomonas aeruginosa. This study demonstrated the in vitro and in vivo safety and efficacy in bacterial reduction of a flexible cold plasma device. Trial registration number NCT03007264, January 2, 2017

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据